These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 12850794
1. Detection of disseminated epithelial cancer cells by liquid culture--factors interfering with the standardization of assays. Krüger WH, Lange A, Badbaran A, Gutensohn K, Kröger N, Zander AR. Cytotherapy; 2003; 5(3):252-8. PubMed ID: 12850794 [Abstract] [Full Text] [Related]
2. Detection of cancer cells in peripheral blood stem cells of women with breast cancer by RT-PCR and cell culture. Krüger WH, Stockschläder M, Hennings S, Aschenbrenner M, Gruber M, Gutensohn K, Löliger C, Gieseking F, Jonat W, Zander AR. Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S18-20. PubMed ID: 8899163 [Abstract] [Full Text] [Related]
3. An immunomagnetic epithelial tumor cell enrichment model for minimal residual disease detection of cytokeratin 8+ malignancies. Brooimans RA, de Leeuw N, Bontenbal M, Gratama JW. J Biol Regul Homeost Agents; 2005 Sep; 19(1-2):84-91. PubMed ID: 16178280 [Abstract] [Full Text] [Related]
4. Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: establishment of working models for human micrometastases. Putz E, Witter K, Offner S, Stosiek P, Zippelius A, Johnson J, Zahn R, Riethmüller G, Pantel K. Cancer Res; 1999 Jan 01; 59(1):241-8. PubMed ID: 9892213 [Abstract] [Full Text] [Related]
5. Detection of disseminated tumor cells in bone marrow of gastric cancer using magnetic activated cell sorting and fluorescent activated cell sorting. Wang GY, Li Y, Yu YM, Yu B, Zhang ZY, Liu Y, Wang SJ. J Gastroenterol Hepatol; 2009 Feb 01; 24(2):299-306. PubMed ID: 19032456 [Abstract] [Full Text] [Related]
6. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Riethdorf S, Fritsche H, Müller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Jänicke F, Jackson S, Gornet T, Cristofanilli M, Pantel K. Clin Cancer Res; 2007 Feb 01; 13(3):920-8. PubMed ID: 17289886 [Abstract] [Full Text] [Related]
7. Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer. Varangot M, Barrios E, Sóñora C, Aizen B, Pressa C, Estrugo R, Lavigna R, Musé I, Osinaga E, Berois N. Oncol Rep; 2005 Aug 01; 14(2):537-45. PubMed ID: 16012742 [Abstract] [Full Text] [Related]
8. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization. Riethdorf S, Pantel K. Pathobiology; 2008 Aug 01; 75(2):140-8. PubMed ID: 18544969 [Abstract] [Full Text] [Related]
9. Tumor cell purging by ex vivo expansion of hemopoietic stem cells from breast cancer patients combined with targeting ErbB receptors. Leone F, Cavalloni G, Gunetti M, Pignochino Y, Piacibello W, Aglietta M. Biol Blood Marrow Transplant; 2006 Jan 01; 12(1):68-74. PubMed ID: 16399570 [Abstract] [Full Text] [Related]
10. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients]. Cai QQ, Huang HQ, Lin TX, Jiang WQ. Ai Zheng; 2005 Jul 01; 24(7):837-41. PubMed ID: 16004811 [Abstract] [Full Text] [Related]
11. Detection and clinical implications of early systemic tumor cell dissemination in breast cancer. Pantel K, Müller V, Auer M, Nusser N, Harbeck N, Braun S. Clin Cancer Res; 2003 Dec 15; 9(17):6326-34. PubMed ID: 14695131 [Abstract] [Full Text] [Related]
12. Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer. Reinholz MM, Nibbe A, Jonart LM, Kitzmann K, Suman VJ, Ingle JN, Houghton R, Zehentner B, Roche PC, Lingle WL. Clin Cancer Res; 2005 May 15; 11(10):3722-32. PubMed ID: 15897569 [Abstract] [Full Text] [Related]
14. Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients. Alix-Panabières C, Brouillet JP, Fabbro M, Yssel H, Rousset T, Maudelonde T, Choquet-Kastylevsky G, Vendrell JP. J Immunol Methods; 2005 Apr 15; 299(1-2):177-88. PubMed ID: 15914200 [Abstract] [Full Text] [Related]
15. Immunomagnetic cell enrichment detects more disseminated cancer cells than immunocytochemistry in vitro. Zigeuner RE, Riesenberg R, Pohla H, Hofstetter A, Oberneder R. J Urol; 2000 Nov 15; 164(5):1834-7. PubMed ID: 11025779 [Abstract] [Full Text] [Related]
16. Minimal residual disease detection in breast cancer: improved sensitivity using cytokeratin 19 and epidermal growth factor receptor RT-PCR. Fellowes VS, Husebekk A, Gress RE, Vance BA. Int J Oncol; 2004 Apr 15; 24(4):861-7. PubMed ID: 15010823 [Abstract] [Full Text] [Related]
19. Rare expression of target antigens for immunotherapy on disseminated tumor cells in breast cancer patients without overt metastases. Kasimir-Bauer S, Otterbach F, Oberhoff C, Schmid KW, Kimmig R, Seeber S. Int J Mol Med; 2003 Dec 15; 12(6):969-75. PubMed ID: 14612976 [Abstract] [Full Text] [Related]
20. Scale-up of breast cancer stem cell aggregate cultures to suspension bioreactors. Youn BS, Sen A, Behie LA, Girgis-Gabardo A, Hassell JA. Biotechnol Prog; 2006 Dec 15; 22(3):801-10. PubMed ID: 16739964 [Abstract] [Full Text] [Related] Page: [Next] [New Search]